Ávila PLM, Torres TC, Ponce D’LLF, Baena Y, Aristizábal FA

Language: Spanish
References: 54
Page: 3-10
PDF size: 105.23 Kb.

ABSTRACT

Stem cells has three common characteristics: self-renewal, differentiation and derivation of any mature cell, these are the assets (in the case of adult stem cell) with which an individual has to regenerate senescent cells along life. Stem cells can regenerate tissue compatible individuals of the same species. In Cosmetic technology the term stem cell refers mainly to stem cells extracted from substances of vegetable origin, rich in polyphenols such as resveratrol, and luteolin or peptides able to activate the genes of the NAD-dependent sirtuins, which produce deacetylation that allow the compaction of chromatin.

REFERENCES

1. Ávila LM, Becerra A, Ávila J, Gómez C, Madero JI. Biología de las Células Stem. Medical Main News 2008; 2: 10-4.

2. Ávila LM, Becerra A, Ávila J, Madero JI. En Infertilidad y Endocrinología Reproductiva “ Biología de las Células Stem”, Cali. Grafaimpresos Donado 2007; 409-22.

3. Munevar JC, Becerra A, Hernández A. Biología de las células Stem. Nova 2005; 3: 1-120.

4. Lu L, Shenavcy RN, Broxmeyer E. Stem cells from bone marrow, umbilical cord blood and peripheral blood for clinical application: current status and future application. Critical Reviews in Oncology/Hematology 1996; 22: 61-78.

5. Ávila LM, Rodríguez L, Ávila J, Madero JI, Gómez C. Tejido graso: una fuente inapreciable de células Stem para terapia regenerativa celular, Colombia. Revista Colombiana de Cirugía Plastica y Reconstructiva 2008; 14: 24-7.

6. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003; 174: 101-9.

7. Slatter MA, Gennery AR. Umbilical cord Stem cell transplantation for primary immunodeficiencies. Expert Opin Biol Ther 2006; 6: 555-65.

8. Ávila LM, Ávila J, Becerra A, Gómez C, Madero JI. Caracterización de los procesos de el Banco de Células Stem de Colombia. V Congreso medicina transfusional. 2008, Cartagena de Indias. Colombia. 2008; 8: 94.

9. Ávila LM, Guzmán J, Rojas C, Becerra A, Ávila J, Jaimes D et al. Viability and functional capacity after thawing of hematopoietic progenitor cells cryopreserved at a cord blood stem cell bank in Colombia. Int J Gynecol Obstet [Epub ahead of print] 2010.

10. Ooi J, Iseki T, Takahashi S, Tomonari A, Takasugi K, Shimohakamada Y et al. Unrelated Cord Blood transplantation for adult patients with de novo acute myeloid leukemia. Blood 2004; 103: 489-91.

11. Cai J, Li W, Su H, Qin D, Yang J, Zhu F et al. Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem 2010; 285: 11227-34.

12. Matikainena T, Laine J. Placenta an alternative source of stem cells. Toxicology and Applied Pharmacology 2005; 207: S544-S549.

13. Duan X, Kang E, Liu Ming GL, Song H. Development of neural stem cell in the adult brain. Curr Opin Neurobiol 2008; 18: 108-15.

14. Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-7.

15. Baber MA. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol 1996; 166: 585-92.

16. Prósper F, Herreros J. Células madre adultas. Rev Argent Cardiol 2004; 72: 68-73.

17. Yoshimura K, Sato K, Matsumoto D. Cellassisted lipotransfer for breast augmentation: grafting of progenitor-enriched fat tissue. In Autologous fat transplantation (Ed. by Shiffman MA), Marcel Dekker, Inc., New York, 2010; 261-71.

18. Yoshimura K, Asano Y, Aoi N, Kurita M, Oshima Y, Sato K et al. Progenitor-enriched adipose tissue transplantation as rescue for breast implant complications. The Breast Journal 2010; 16: 169-75.

19. Rangappa S, Fen C, Lee EH, Bongso A, Kwang ES. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann Thorac Surg 2003; 75: 775-9.

20. Zouboulis CC, Adjaye J, Akamatsu H, Moe- Behrens G, Niemann C. Human skin stem cells and the ageing process. Experimental Gerontology 2008; 43: 986-97.

21. Barker N, Huch M, Kujala P, Van de WM, Snippert J, Van Es HET et al. Lgr5 Stem Cells Drive Self-Renewal in the Stomach and Build Long-Lived Gastric Units In Vitro. Stem Cell 2010; 6: 25-36.

22. Fuchs E. Skin stem cell, rising to the surface. J Cell Biol 2008; 180: 273-84.

23. Stark HJ, Willhauck MJ, Mirancea N, Boehnke K, Nord I, Breitkreutz D et al. Authentic fibroblast matrix in dermal equivalents normalises epidermal histogenesis and dermoepidermal junction in organotypic co-culture. Eur J Cell Biol 2004; 83: 631-45.

24. Van Zant G, Liang Y. The role of stem cells in aging. Experimental Hematology 2003; 31: 659-72.

25. Hensley K, Floyd RA. Reactive oxygen species and protein oxidation in aging: a look back, a look ahead. Arch Biochem Biophys 2002; 397: 377-83.

26. Kim WS, Park BS, Park SH et al. Antiwrinkle effect of adipose-derived stem cell: Activation of dermal fibroblast by secretory factors. J Dermatol Sci 2009; 53: 96-102.

27. Martin-Rendon E, Brunskill S, Hyde CJ, Stanworth SJ, Mathur A, Watt S. Autologous bone marrow Stem cells to treat acute Myocardial Infarction: a systematic review. European Heart Journal 2008; 29: 1807-18.

28. Couri CE, Voltarelli JC. Peptide Levels and Insulin Independence Following Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus. JAMA 2009; 301: 1573-9.

29. Geffner LE, Santacruz P, Izurieta M, FLor L, Maldonado B, Auad AH et al. Administration of autologous Bone Marrow Stem Cells Into Spinal Cord Injury Patients Via Multiple Routes Is safe and Improves their Quality of life: Comprehensive Case studies. Cell Transplantion 2008; 17: 1277-93.

30. Reyes E, Arbelaez AM, Ávila LM, Ospino B, Bello JM, Jaimes D, Londońo J, Valle R. Autotrasplante exitoso de células madre hematopoyéticas en una mujer con Esclerosis sistémica Severa refractaria al manejo inmunosupresor. Revista Colombiana de Reumatología 2009; 16: 375-81.

31. Ávila LM, Franco C, Segura D, Pullas G, Pareja L, Ospino B et al. Células madre en pacientes con Enfermedad Oclusiva Crónica de miembros inferiores. Congreso de Fertilidad y Medicina Reproductiva. Bogotá, 2009.

32. Kelley JM. Inmunología, Biología molecular y la enfermedad. Rev Med Clin Condes 2007; 18: 287-97.

33. Majumdar MK, Thiede MA, Haynesworth SE et al. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 2000; 841-8.

34. Kilroy GE, Foster SJ, Wu X et al. Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 2007; 212: 702-9.

35. Park BS, Jang K, Sung JH et al. Adipose- Derived Stem cells and their secretory factors as a promising therapy for skin aging. Dermatol Surg 2008; 34: 1323-6.

36. Abarbanell AM, Coffey AC, Fehrenbacher JW, Beckman DJ, Herrmann JL, Weil B, Meldru DR. Proinflammatory Cytokine Effects on Mesenchymal Stem Cell Therapy for the Ischemic Heart. The Annals of Thoracic Surgery 2009; 88: 1036-43.

37. Roobrouck VD, Ulloa-Montoya F, Verfaillie CM. Self-renewal and differentiation capacity of young and aged stem cells. Experimental cell research 2008; 314: 1937-44.

38. Peńa B. Dior y las células madre de Capture XP capturan el lujo científico de LVMH. www.bellezapura.com/2008/03/27/dior-y-lascelulas-madre-de-capture-xp-capturan-ellujo-cientifico-de-lvmh/, Abril 2010.

39. Masor EJ. Role of sirtuin proteins in life extension by caloric restriction. Mechanisms of Ageing and Development 2004; 125: 591-4.

40. Equipo Tórrese. Cosmética de presente y futuro. http://www.39ymas.com/temas/belleza/cosmetica-presente-futuro/mayo del 2010

41. http://www.esteelauder.com/product/spp.tmpl?CATEGORY_ID=CAT668&PRODUCT_ID=3507. Re-Nutriv Ultimate Youth Crem, Mayo 2010.

42. Puertas M. La cosmética del futuro. www.hoymujer.com/belleza/tendencias/cosmetica, futuro,52149,03,2008.html. Abril de 2010

43. Farina A, Ferranti C, Marra C. An improved synthesis of resveratrol. Nat Prod Res 2006; 20: 247-52.

44. Ulubelen A, Miski M, Neuman P, Mabry TJ. Flavonoids of Salvia tomentosa Labiatae. Journal of Natural Products 1979; 42: 261-3.

45. Botchkarev AV, Mina Y, Peters E, Siba Raychaudhuri P, Botchkareva VN, Marconi A et al. Neurotrophins in Skin Biology and Pathology. Journal of Investigative Dermatology 2006; 126: 1719-27.

46. Westphal CH, Dipp MA, Guarente L. A therapeutic role for sirtuins in diseases of aging? Trends in Biochemical Sciences 2007; 32: 555-9.

47. Adams JD, Klaidman LK. Sirtuins, Nicotinamide and Aging: A Critical Review. Letters in Drug Design & Discovery 2007; 4: 44-8.

48. Dani C, Oliboni LS, Vanderlinde R, Pra D, Dias JF, Yoneama ML et al. Antioxidant activity and phenolic and mineral content of rose grape juice. J Med Food 2009; 12: 188-92.

49. Greiss S, Hall J, Ahmed S, Gartner A. C. Elegans SIR-2.1 translocation is linked to a proapoptotic pathway parallel to cep-1/p53 during DNA damage-induced apoptosis. Genes y Development 2008; 22: 2831-42.

50. Dervis AM, Brunet A. Foxo transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol 2008; 20: 126-36.

51. Yeung F, Jamie E, Hoberg C, Ramsey S, Keller M, Jones D. Modulation of NF-kBdependent transcription and cell survival by the SIRT1 deacetylase. EMBO Journal 2004; 23: 2369-80.

52. Sinclair DA, Guarente L. Circles a cause of aging in yeast. Cell 1997; 91: 1033-42.

53. Costantini AS, Colonna G. Human Sirt-1: Molecular Modeling and Structure-Function Relationships of an Unordered Protein. PLoS ONE 2009; 4: e7350.

54. Ulrich S, Loitsch SM, Rau O, Von Knethen A, Brüne B, Schubert-Zsilavecz M, Stein JM. Peroxisome Proliferator-Activated Receptor as a Molecular Target of Resveratrol-Induced Modulation of Polyamine Metabolism. Cancer Res 2006; 66: 7348-54.